RecentMedicalFindings.com
Summarizing relevant biomedical research!
drug induced tic disorder     Bookmark and Share
Search webpages of this site (RecentMedicalFindings):
Didn't find what you wanted? Try it at BioMedLib™ !
Search directly on the biomedical articles using BioMedLib™ search engine:



1. Biomedical articles (top 16; 2009 to 2014)
1. |||||..... 50%  Calarge CA, Ellingrod VL, Acion L, Miller DD, Moline J, Tansey MJ, Schlechte JA: Variants of the dopamine D2 receptor gene and risperidone-induced hyperprolactinemia in children and adolescents. Pharmacogenet Genomics; 2009 May;19(5):373-82
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Variants of the dopamine D2 receptor gene and risperidone-induced hyperprolactinemia in children and adolescents.
  • The effect of the TaqIA variants of the DRD2 on the risk of risperidone-induced hyperprolactinemia was the primary outcome measure.
  • [MeSH-major] Hyperprolactinemia / chemically induced. Hyperprolactinemia / genetics. Polymorphism, Genetic / physiology. Receptors, Dopamine D2 / genetics. Risperidone / adverse effects
  • [MeSH-minor] Adolescent. Antipsychotic Agents / adverse effects. Antipsychotic Agents / therapeutic use. Child. Child Behavior Disorders / drug therapy. Child Behavior Disorders / genetics. Female. Gene Frequency. Genetic Predisposition to Disease. Humans. Linkage Disequilibrium. Male. Obsessive-Compulsive Disorder / drug therapy. Obsessive-Compulsive Disorder / genetics. Prolactin / blood. Retrospective Studies. Tic Disorders / drug therapy. Tic Disorders / genetics

  • HSDB. structure - RISPERIDONE.
  • COS Scholar Universe. author profiles.
  • ExactAntigen/Labome. author profiles.
  • Pharmacogenomics Knowledge Base. meta-databases - Pharmacogenomic Annotation 827856676 for PMID:19339912 [PharmGKB] .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] J Am Acad Child Adolesc Psychiatry. 2000 Jan;39(1):28-38 [10638065.001]
  • [Cites] Methods Mol Biol. 2003;212:189-95 [12491911.001]
  • [Cites] Pharmacogenetics. 1999 Aug;9(4):505-9 [10780270.001]
  • [Cites] Psychopharmacology (Berl). 2000 Apr;149(3):246-50 [10823405.001]
  • [Cites] JAMA. 2001 Feb 14;285(6):785-95 [11176917.001]
  • [Cites] J Child Adolesc Psychopharmacol. 2001 Spring;11(1):15-24 [11322741.001]
  • [Cites] Am J Med Genet. 2001 Apr 8;105(3):271-4 [11353448.001]
  • [Cites] Am J Psychiatry. 2002 Aug;159(8):1337-46 [12153826.001]
  • [Cites] J Am Acad Child Adolesc Psychiatry. 2003 Feb;42(2):132-44 [12544173.001]
  • [Cites] J Am Acad Child Adolesc Psychiatry. 2003 Feb;42(2):145-61 [12544174.001]
  • [Cites] Hum Mol Genet. 2003 Feb 1;12(3):205-16 [12554675.001]
  • [Cites] Neurochem Res. 2003 Jan;28(1):73-82 [12587665.001]
  • [Cites] Psychoneuroendocrinology. 2003 Apr;28 Suppl 2:69-82 [12650682.001]
  • [Cites] J Am Acad Child Adolesc Psychiatry. 2003 Jun;42(6):625-6 [12921468.001]
  • [Cites] J Clin Psychiatry. 2003 Nov;64(11):1362-9 [14658952.001]
  • [Cites] JAMA. 2004 Jan 14;291(2):228-38 [14722150.001]
  • [Cites] Schizophr Res. 2004 Mar 1;67(1):75-85 [14741327.001]
  • [Cites] Br J Psychiatry. 2004 Aug;185:147-51 [15286066.001]
  • [Cites] Life Sci. 1990;46(9):625-33 [2308471.001]
  • [Cites] Arch Gen Psychiatry. 1991 Jul;48(7):648-54 [2069496.001]
  • [Cites] Hum Mol Genet. 1997 Apr;6(4):577-82 [9097961.001]
  • [Cites] Mol Psychiatry. 1998 May;3(3):256-60 [9672901.001]
  • [Cites] J Clin Psychopharmacol. 1998 Aug;18(4):305-10 [9690696.001]
  • [Cites] Mol Psychiatry. 1999 May;4(3):290-6 [10395223.001]
  • [Cites] Mol Psychiatry. 2004 Dec;9(12):1060-1 [15278099.001]
  • [Cites] Bioinformatics. 2005 Jan 15;21(2):263-5 [15297300.001]
  • [Cites] Pharmacogenet Genomics. 2005 Jun;15(6):387-91 [15900211.001]
  • [Cites] N Engl J Med. 2005 Sep 22;353(12):1209-23 [16172203.001]
  • [Cites] J Child Adolesc Psychopharmacol. 2005 Dec;15(6):893-900 [16379509.001]
  • [Cites] Am J Psychiatry. 2006 Mar;163(3):529-31 [16513877.001]
  • [Cites] Arch Gen Psychiatry. 2006 Jun;63(6):679-85 [16754841.001]
  • [Cites] J Child Adolesc Psychopharmacol. 2006 Jun;16(3):317-26 [16768639.001]
  • [Cites] J Am Acad Child Adolesc Psychiatry. 2006 Jul;45(7):771-91 [16832314.001]
  • [Cites] Pediatr Res. 2006 Nov;60(5):513-7 [16966351.001]
  • [Cites] J Am Acad Child Adolesc Psychiatry. 2006 Nov;45(11):1284-93 [17023867.001]
  • [Cites] J Clin Psychopharmacol. 2007 Feb;27(1):52-7 [17224713.001]
  • [Cites] Biol Psychiatry. 2007 Feb 15;61(4):545-50 [16730335.001]
  • [Cites] J Am Acad Child Adolesc Psychiatry. 2007 Aug;46(8):1015-27 [17667480.001]
  • [Cites] Pharmacogenet Genomics. 2007 Nov;17(11):989-93 [18075468.001]
  • [Cites] Proc Natl Acad Sci U S A. 2007 Dec 18;104(51):20552-7 [18077373.001]
  • [Cites] Prog Neuropsychopharmacol Biol Psychiatry. 2008 Aug 1;32(6):1491-5 [18579277.001]
  • [Cites] J Child Adolesc Psychopharmacol. 2009 Apr;19(2):101-9 [19364288.001]
  • [Cites] Clin Endocrinol (Oxf). 2000 Mar;52(3):319-27 [10718830.001]
  • (PMID = 19339912.001).
  • [ISSN] 1744-6872
  • [Journal-full-title] Pharmacogenetics and genomics
  • [ISO-abbreviation] Pharmacogenet. Genomics
  • [Language] eng
  • [Grant] United States / NIMH NIH HHS / MH / K23 MH085005-03; United States / NCRR NIH HHS / RR / M01 RR000059-466771; United States / NCRR NIH HHS / RR / RR00059
  • [Publication-type] Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Antipsychotic Agents; 0 / Receptors, Dopamine D2; 9002-62-4 / Prolactin; L6UH7ZF8HC / Risperidone
  • [Other-IDs] NLM/ NIHMS99305; NLM/ PMC2699901
  •  go-up   go-down


2. |||||||... 75%  Walkup JT, Ferrão Y, Leckman JF, Stein DJ, Singer H: Tic disorders: some key issues for DSM-V. Depress Anxiety; 2010 Jun;27(6):600-10
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Tic disorders: some key issues for DSM-V.
  • This study provides a focused review of issues that are relevant to the nosology of the tic disorders and presents preliminary recommendations to be considered for DSM-V.
  • The recommended changes are designed to clarify and simplify the diagnostic criteria, reduce the use of the residual category, tic disorder not otherwise specified, and are not intended to alter substantially clinical practice or the continuity of past and future research.
  • (1) a more precise definition of motor and vocal tics;.
  • (2) simplification of the duration criterion for the tic disorders;.
  • (3) revising the term "transient tic disorder" for those with tic symptoms of less than 12-month duration;.
  • (4) establishing new tic disorder categories for those with substance induced tic disorder and tic disorder due to a general medical condition; and (5) including a motor tic only and vocal tic only specifier for the chronic motor or vocal tic disorder category.
  • [MeSH-major] Diagnostic and Statistical Manual of Mental Disorders. Tic Disorders / diagnosis
  • [MeSH-minor] Age Factors. Attention Deficit Disorder with Hyperactivity / drug therapy. Attention Deficit Disorder with Hyperactivity / epidemiology. Central Nervous System Stimulants / therapeutic use. Comorbidity. Humans. Substance-Related Disorders / epidemiology

  • COS Scholar Universe. author profiles.
  • ExactAntigen/Labome. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] (c) 2010 Wiley-Liss, Inc.
  • (PMID = 20533370.001).
  • [ISSN] 1520-6394
  • [Journal-full-title] Depression and anxiety
  • [ISO-abbreviation] Depress Anxiety
  • [Language] eng
  • [Publication-type] Journal Article; Review
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Central Nervous System Stimulants
  • [Number-of-references] 68
  •  go-up   go-down


3. |||||||... 72%  Zhou YB, Wu M, Yan XJ: [Effect of qufeng zhidong recipe on neuroethology and mRNA expressions of Notch1 and D2R in mouse with tic disorder]. Zhongguo Zhong Xi Yi Jie He Za Zhi; 2009 Jun;29(6):519-23
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Effect of qufeng zhidong recipe on neuroethology and mRNA expressions of Notch1 and D2R in mouse with tic disorder].
  • OBJECTIVE: To evaluate the effect of Qufeng Zhidong Recipe (QZR) on the head tic behavior, and the mRNA expressions of Notch1 and dopamine D2 receptor (D2R) in tic disordered mice.
  • METHODS: Mouse model like wet-dog shake head tic disorder was established by peritoneal injection of 5-HT2A/C agonist DOI for 14 successive days.
  • The effect of intervention was evaluated 2 weeks later by estimating the head tic and the creeping distance of animals, and the mRNA expressions of D2R and Notch1 in corpus striatum and prefrontal cortex regions were detected using Real-time PCR.
  • CONCLUSION: DOI-induced wet-dog shake response could well simulate the clinical characteristics of tic disorder; QZR could improve the tic behavior and creeping distance in the model mice.
  • [MeSH-major] Drugs, Chinese Herbal / therapeutic use. Phytotherapy. Receptor, Notch1 / metabolism. Receptors, Dopamine D2 / metabolism. Tic Disorders / drug therapy
  • [MeSH-minor] Animals. Corpus Striatum / metabolism. Male. Mice. Mice, Inbred C57BL. RNA, Messenger / genetics. RNA, Messenger / metabolism. Random Allocation. Signal Transduction / drug effects

  • MedlinePlus Health Information. consumer health - Herbal Medicine.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19702084.001).
  • [ISSN] 1003-5370
  • [Journal-full-title] Zhongguo Zhong xi yi jie he za zhi Zhongguo Zhongxiyi jiehe zazhi = Chinese journal of integrated traditional and Western medicine / Zhongguo Zhong xi yi jie he xue hui, Zhongguo Zhong yi yan jiu yuan zhu ban
  • [ISO-abbreviation] Zhongguo Zhong Xi Yi Jie He Za Zhi
  • [Language] chi
  • [Publication-type] English Abstract; Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] China
  • [Chemical-registry-number] 0 / Drugs, Chinese Herbal; 0 / Notch1 protein, mouse; 0 / RNA, Messenger; 0 / Receptor, Notch1; 0 / Receptors, Dopamine D2; 0 / qufeng zhidong
  •  go-up   go-down


Advertisement

4. |||||||... 71%  Wu M, Ma BT, Wang SX: [Effect of qufeng zhidong simplified recipe on the behavior of the tic disorder rats]. Zhongguo Zhong Xi Yi Jie He Za Zhi; 2011 Oct;31(10):1369-72
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Effect of qufeng zhidong simplified recipe on the behavior of the tic disorder rats].
  • OBJECTIVE: To study the effects qufeng zhidong Simplified Recipe (QZSR) on the behavior of the tic disorder (TD) rats.
  • CONCLUSION: QZSR could significantly reduce APO induced stereotyped behavior scores of TD rats, improve their locomotor activities, and reinforce their adaptive faculty.
  • [MeSH-major] Behavior, Animal / drug effects. Drugs, Chinese Herbal / pharmacology. Tic Disorders / drug therapy. Tic Disorders / psychology

  • ExactAntigen/Labome. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 22097207.001).
  • [ISSN] 1003-5370
  • [Journal-full-title] Zhongguo Zhong xi yi jie he za zhi Zhongguo Zhongxiyi jiehe zazhi = Chinese journal of integrated traditional and Western medicine / Zhongguo Zhong xi yi jie he xue hui, Zhongguo Zhong yi yan jiu yuan zhu ban
  • [ISO-abbreviation] Zhongguo Zhong Xi Yi Jie He Za Zhi
  • [Language] chi
  • [Publication-type] English Abstract; Journal Article; Research Support, U.S. Gov't, Non-P.H.S.
  • [Publication-country] China
  • [Chemical-registry-number] 0 / Drugs, Chinese Herbal; 0 / qufeng zhidong
  •  go-up   go-down


5. |||||..... 50%  Yaddanapudi K, Hornig M, Serge R, De Miranda J, Baghban A, Villar G, Lipkin WI: Passive transfer of streptococcus-induced antibodies reproduces behavioral disturbances in a mouse model of pediatric autoimmune neuropsychiatric disorders associated with streptococcal infection. Mol Psychiatry; 2010 Jul;15(7):712-26
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Passive transfer of streptococcus-induced antibodies reproduces behavioral disturbances in a mouse model of pediatric autoimmune neuropsychiatric disorders associated with streptococcal infection.
  • Streptococcal infections can induce obsessive-compulsive and tic disorders.
  • [MeSH-major] Autoantibodies / immunology. Autoimmune Diseases / psychology. Behavior, Animal / drug effects. Disease Models, Animal. Obsessive-Compulsive Disorder / psychology. Streptococcal Infections / psychology. Streptococcus pyogenes / immunology. Tic Disorders / immunology


6. |||||..... 50%  Worbe Y, Sgambato-Faure V, Epinat J, Chaigneau M, Tandé D, François C, Féger J, Tremblay L: Towards a primate model of Gilles de la Tourette syndrome: anatomo-behavioural correlation of disorders induced by striatal dysfunction. Cortex; 2013 Apr;49(4):1126-40
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Towards a primate model of Gilles de la Tourette syndrome: anatomo-behavioural correlation of disorders induced by striatal dysfunction.
  • INTRODUCTION: Gilles de la Tourette syndrome (GTS) is characterized by abnormal movements (tics) often associated with behavioural disorders.
  • In a monkey model, injections of GABA-antagonist into the striatum enabled us to produce tic-like movements, hyperactivity and stereotyped behaviours.
  • These effects had similarities with simple motor tics, hyperactivity and compulsive behaviours observed in GTS patients.
  • METHODS: Using injections of axonal tracer into different functional parts of the striatum of eight monkeys, we identified cortical, thalamic and basal ganglia regions related to the expression of tic-like movements, hyperactivity and stereotyped behaviours induced in response to microinjection of GABA-antagonist.
  • Thus, tic-like movements were associated with neuronal labelling within the sensorimotor network, mostly in the medial and lateral premotor cortex and sensorimotor parts of the basal ganglia.
  • Neuronal labelling in the prefrontal dorso-lateral cortex and associative territories of the basal ganglia was related to hyperactivity disorder and stereotyped behaviours were linked to the orbitofrontal cortex and limbic part of the basal ganglia.
  • As these behavioural disorders shared some similarities with simple motor tics, hyperactivity and compulsive behaviours observed in GTS patients, this model could be a good tool for future studies involving the modulation of neuronal circuits, such as deep brain stimulation.
  • [MeSH-minor] Afferent Pathways / pathology. Afferent Pathways / physiopathology. Animals. Axons / physiology. Behavior, Animal / drug effects. Bicuculline / administration & dosage. Bicuculline / pharmacology. Cercopithecus aethiops. Disease Models, Animal. Efferent Pathways / pathology. Efferent Pathways / physiopathology. GABA Antagonists / administration & dosage. GABA Antagonists / pharmacology. Macaca fascicularis. Macaca mulatta. Male. Microinjections. Stereotyped Behavior

  • MedlinePlus Health Information. consumer health - Tourette Syndrome.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Copyright © 2012 Elsevier Ltd. All rights reserved.
  • (PMID = 23040317.001).
  • [ISSN] 1973-8102
  • [Journal-full-title] Cortex; a journal devoted to the study of the nervous system and behavior
  • [ISO-abbreviation] Cortex
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Italy
  • [Chemical-registry-number] 0 / GABA Antagonists; Y37615DVKC / Bicuculline
  •  go-up   go-down


7. |||||..... 47%  Pourcher E, Rémillard S, Cohen H: Compulsive habits in restless legs syndrome patients under dopaminergic treatment. J Neurol Sci; 2010 Mar 15;290(1-2):52-6
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Since the introduction of levodopa therapy and dopaminergic replacement therapy to abate symptoms of idiopathic Parkinson's disease, repetitive compulsive behaviors have been reported and are now considered to be drug-related response complications.
  • In addition, two women presented new tic-like phenomena.
  • [MeSH-major] Benzothiazoles / adverse effects. Compulsive Behavior / chemically induced. Dopamine Agonists / adverse effects. Obsessive-Compulsive Disorder / chemically induced. Restless Legs Syndrome / drug therapy
  • [MeSH-minor] Adult. Aged. Depressive Disorder / chemically induced. Eating Disorders / chemically induced. Female. Gambling / psychology. Health Status. Health Surveys. Humans. Limbic System / drug effects. Limbic System / metabolism. Limbic System / physiopathology. Male. Middle Aged. Mood Disorders / complications. Mood Disorders / physiopathology. Questionnaires. Reward. Sleep Disorders / chemically induced. Stress, Psychological / complications. Stress, Psychological / physiopathology. Trichotillomania / chemically induced

  • MedlinePlus Health Information. consumer health - Obsessive-Compulsive Disorder.
  • MedlinePlus Health Information. consumer health - Restless Legs.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19969309.001).
  • [ISSN] 1878-5883
  • [Journal-full-title] Journal of the neurological sciences
  • [ISO-abbreviation] J. Neurol. Sci.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] Netherlands
  • [Chemical-registry-number] 0 / Benzothiazoles; 0 / Dopamine Agonists; 83619PEU5T / pramipexole; E78ZFF4KQ0 / Reward
  •  go-up   go-down


8. |||||..... 47%  Cortese S, Holtmann M, Banaschewski T, Buitelaar J, Coghill D, Danckaerts M, Dittmann RW, Graham J, Taylor E, Sergeant J, European ADHD Guidelines Group: Practitioner review: current best practice in the management of adverse events during treatment with ADHD medications in children and adolescents. J Child Psychol Psychiatry; 2013 Mar;54(3):227-46
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • RESULTS: The review covers monitoring and management strategies of loss of appetite and growth delay, cardiovascular risks, sleep disturbance, tics, substance misuse/abuse, seizures, suicidal thoughts/behaviours and psychotic symptoms.
  • [MeSH-major] Attention Deficit Disorder with Hyperactivity / drug therapy. Central Nervous System Stimulants / adverse effects
  • [MeSH-minor] Adolescent. Blood Pressure / drug effects. Body Size / drug effects. Cardiovascular Diseases / chemically induced. Cardiovascular Diseases / prevention & control. Child. Clonidine / adverse effects. Dextroamphetamine / adverse effects. Growth Disorders / chemically induced. Guanfacine / adverse effects. Heart Rate / drug effects. Humans. Methylphenidate / administration & dosage. Methylphenidate / adverse effects. Propylamines / administration & dosage. Propylamines / adverse effects. Psychoses, Substance-Induced. Seizures / chemically induced. Seizures / therapy. Sleep Disorders / chemically induced. Sleep Disorders / therapy. Substance-Related Disorders / etiology. Substance-Related Disorders / therapy. Suicide / prevention & control. Tic Disorders / chemically induced. Tic Disorders / therapy. Treatment Outcome

  • MedlinePlus Health Information. consumer health - Attention Deficit Hyperactivity Disorder.
  • HSDB. structure - METHYLPHENIDATE.
  • HSDB. structure - CLONIDINE.
  • HSDB. structure - DEXTROAMPHETAMINE.
  • HSDB. structure - ATOMOXETINE.
  • ExactAntigen/Labome. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] © 2013 The Authors. Journal of Child Psychology and Psychiatry © 2013 Association for Child and Adolescent Mental Health.
  • (PMID = 23294014.001).
  • [ISSN] 1469-7610
  • [Journal-full-title] Journal of child psychology and psychiatry, and allied disciplines
  • [ISO-abbreviation] J Child Psychol Psychiatry
  • [Language] eng
  • [Publication-type] Journal Article; Practice Guideline; Research Support, Non-U.S. Gov't; Review
  • [Publication-country] England
  • [Chemical-registry-number] 0 / Central Nervous System Stimulants; 0 / Propylamines; 207ZZ9QZ49 / Methylphenidate; 30OMY4G3MK / Guanfacine; ASW034S0B8 / atomoxetine; MN3L5RMN02 / Clonidine; SJT761GEGS / lisdexamfetamine dimesylate; TZ47U051FI / Dextroamphetamine
  • [Investigator] Banaschewski T; Brandeis D; Buitelaar J; Coghill D; Cortese S; Daley D; Danckaerts M; Dittmann R; Döpfner M; Ferrin M; Graham J; Hollis C; Holtmann M; Konofal E; Lecendreux M; Rothenberger A; Santosh P; Sergeant JA; Simonoff E; Sonuga-Barke EJ; Steinhausen H-; Stringaris A; Taylor E; van der Oord S; Wong I; Zuddas A; Sergeant J
  •  go-up   go-down


9. |||||..... 47%  Minns AB, Clark RF, Schneir A: Guanfacine overdose resulting in initial hypertension and subsequent delayed, persistent orthostatic hypotension. Clin Toxicol (Phila); 2010 Feb;48(2):146-8
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • INTRODUCTION: Guanfacine is an alpha(2)-adrenoreceptor agonist used for the treatment of attention-deficit hyperactivity disorder and tic disorders.
  • [MeSH-major] Adrenergic alpha-Agonists / poisoning. Guanfacine / poisoning. Hypertension / chemically induced. Hypotension, Orthostatic / chemically induced
  • [MeSH-minor] Adolescent. Blood Pressure / drug effects. Drug Overdose. Electrocardiography. Female. Humans. Time Factors. Tourette Syndrome / drug therapy

  • MedlinePlus Health Information. consumer health - High Blood Pressure.
  • ExactAntigen/Labome. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20136479.001).
  • [ISSN] 1556-9519
  • [Journal-full-title] Clinical toxicology (Philadelphia, Pa.)
  • [ISO-abbreviation] Clin Toxicol (Phila)
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] England
  • [Chemical-registry-number] 0 / Adrenergic alpha-Agonists; 30OMY4G3MK / Guanfacine
  •  go-up   go-down


10. |||....... 32%  Levy F: Stimulant side effects and inverted-U: implications for ADHD guidelines. Aust N Z J Psychiatry; 2013 Mar;47(3):217-21
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • OBJECTIVE: To review literature relevant to a possible prediction of stimulant side effects in attention deficit hyperactivity disorder (ADHD), with implications for guidelines.
  • [MeSH-major] Attention Deficit Disorder with Hyperactivity / drug therapy. Central Nervous System Stimulants / adverse effects. Prefrontal Cortex / drug effects
  • [MeSH-minor] Catechol O-Methyltransferase / genetics. Dopamine Plasma Membrane Transport Proteins / genetics. Guidelines as Topic. Humans. Polymorphism, Genetic. Tic Disorders / chemically induced. Tic Disorders / genetics

  • MedlinePlus Health Information. consumer health - Attention Deficit Hyperactivity Disorder.
  • ExactAntigen/Labome. author profiles.
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 22689336.001).
  • [ISSN] 1440-1614
  • [Journal-full-title] The Australian and New Zealand journal of psychiatry
  • [ISO-abbreviation] Aust N Z J Psychiatry
  • [Language] eng
  • [Publication-type] Journal Article; Review
  • [Publication-country] England
  • [Chemical-registry-number] 0 / Central Nervous System Stimulants; 0 / Dopamine Plasma Membrane Transport Proteins; EC 2.1.1.6 / Catechol O-Methyltransferase
  •  go-up   go-down


15. |......... 8%  Musiek ES, Anderson CT, Dahodwala NA, Pollard JR: Facial tic associated with lamotrigine in adults. Mov Disord; 2010 Jul 30;25(10):1512-3
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Facial tic associated with lamotrigine in adults.
  • [MeSH-major] Anticonvulsants / adverse effects. Face. Tic Disorders / chemically induced. Triazines / adverse effects
  • [MeSH-minor] Adult. Epilepsy, Generalized / drug therapy. Humans. Male

  • HSDB. structure - LAMOTRIGINE.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20629145.001).
  • [ISSN] 1531-8257
  • [Journal-full-title] Movement disorders : official journal of the Movement Disorder Society
  • [ISO-abbreviation] Mov. Disord.
  • [Language] eng
  • [Publication-type] Case Reports; Letter
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Anticonvulsants; 0 / Triazines; U3H27498KS / lamotrigine
  •  go-up   go-down


16. |......... 6%  Lai CH: Aripiprazole treatment in an adolescent patient with chronic motor tic disorder and treatment-resistant obsessive-compulsive disorder. Int J Neuropsychopharmacol; 2009 Oct;12(9):1291-3
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Aripiprazole treatment in an adolescent patient with chronic motor tic disorder and treatment-resistant obsessive-compulsive disorder.
  • [MeSH-major] Antipsychotic Agents / therapeutic use. Dopamine Agents / therapeutic use. Drug Resistance. Obsessive-Compulsive Disorder / drug therapy. Piperazines / therapeutic use. Quinolones / therapeutic use. Tic Disorders / drug therapy
  • [MeSH-minor] Adolescent. Chronic Disease. Dizziness / chemically induced. Humans. Male. Psychiatric Status Rating Scales. Treatment Outcome

  • MedlinePlus Health Information. consumer health - Obsessive-Compulsive Disorder.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19706223.001).
  • [ISSN] 1469-5111
  • [Journal-full-title] The international journal of neuropsychopharmacology / official scientific journal of the Collegium Internationale Neuropsychopharmacologicum (CINP)
  • [ISO-abbreviation] Int. J. Neuropsychopharmacol.
  • [Language] eng
  • [Publication-type] Letter
  • [Publication-country] England
  • [Chemical-registry-number] 0 / Antipsychotic Agents; 0 / Dopamine Agents; 0 / Piperazines; 0 / Quinolones; 82VFR53I78 / aripiprazole
  •  go-up   go-down


top


2. Definitions


3. Related RMF webpages
1. drug induced tic disorder
2. drug induced sleep disorder
3. drug induced myopathy disorder
4. drug induced delirium disorder
5. drug induced anxiety disorder
6. drug induced dystonia disorder
7. drug induced obesity disorder
8. drug induced hypotension disorder
9. drug induced pemphigus disorder
10. drug induced myoclonus disorder
11. drug induced chorea disorder
12. drug induced thyroiditis disorder
13. drug induced osteoporosis disorder
14. drug induced psychotic disorder with delusions
15. drug induced myelopathy
16. drug induced eczema
17. drug induced depression
18. drug induced psychosis
19. dyskinesia drug induced
20. drug induced tremor
21. akathisia drug induced
22. drug induced lupus
23. abnormalities drug induced
24. drug induced gout
25. adrenal insufficiency drug induced
26. bone necrosis drug induced
27. drug induced cushing's syndrome
28. drug induced haemolytic anaemia
29. drug induced paranoid state
30. drug induced mental disorders
31. osteomalacia adult drug induced
32. drug induced osteoporosis forearm
33. drug induced sexual dysfunction
34. drug induced ulcer of esophagus
35. drug induced osteoporosis hand
36. hepatitis chronic drug induced
37. drug induced tardive dyskinesia
38. sclerosis systemic drug induced
39. autoimmune hemolytic anemia drug induced
40. drug induced osteoporosis other site
41. drug induced interstitial lung disorders
42. drug induced circadian rhythm sleep disorders
43. tic disorder transient
44. habit tic disorder
45. motor or vocal tic disorder chronic
46. tic disorder disorder
47. tic disorders
48. organic tic
49. tic compulsive
50. tic transient

top


terms of use | advertising programs | contact us
© 2014 RecentMedicalFindings


Connect with the


RMF


audience;




Post your ad here!